Loading...

The current price of DMAA is 10.3523 USD — it has increased 0 % in the last trading day.
Drugs Made In America Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to focus its search for businesses in the pharmaceutical industry. The Company has neither engaged in any operations nor generated any revenues.
Wall Street analysts forecast DMAA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for DMAA is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Drugs Made In America Acquisition Corp revenue for the last quarter amounts to -263.70K USD, decreased % YoY.
Drugs Made In America Acquisition Corp. EPS for the last quarter amounts to -56108.00 USD, decreased % YoY.
Drugs Made In America Acquisition Corp (DMAA) has 0 emplpoyees as of December 15 2025.
Today DMAA has the market capitalization of 346.98M USD.